The Pandemic Crushed the Flu—What Happens When It Returns?

Cases of influenza and other respiratory viruses sank dramatically during the pandemic, with potential implications for both people and pathogens.

Written byDiana Kwon
| 8 min read
three children outside with winter gear wearing surgical masks

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

ABOVE: © ISTOCK.COM, LMGORTHAND

During the annual flu season, many people experience the usual symptoms: a runny nose, sneezing, body aches, and fever. Flu can also be deadly. In the United States alone, influenza viruses cause hundreds of thousands of hospitalizations and tens of thousands of fatalities each year. During the pandemic, however, a drastic change occurred: there was a precipitous drop in infections with influenza and other respiratory viruses—and in some parts of the world, some of these pathogens are nowhere to be found.

“It’s really dramatic how the flu disappeared this year,” says Ellen Foxman, an immunologist at Yale University. At Yale-New Haven Hospital, where Foxman works, there were around 3,000 confirmed flu cases in the first three months of 2020, Foxman tells The Scientist. “This year, from the first of January until now, there’s zero.”

Mask wearing, social distancing, and other restrictions implemented to stave off SARS-CoV-2 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies